Xinping Wang

Xinping Wang

Auto-generated profile, based on publicly available information

Xinping Wang

Department of Neurology, The Third Affiliated Hospital of Qiqihar Medical University

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 May 2021 in Postgraduate Medicine
Verified
Journal Article
Closed access
YGYalin Guan
Yalin Guan
CYChangshen Yu
Changshen Yu
WZWenchao Zuo
Wenchao Zuo
KJKun Jia
Kun Jia
FLFeng Liu
Feng Liu
XWXinping Wang
Xinping Wang
Objective: Small-vessel occlusions are the most common causes of mild strokes and, in China, account for approximately 27.3% of ischemic stroke cases. However, the factors associated with short- and long-term outcomes appear contradictory. Thus, we assessed the factors related to outcomes 3 years after small-vessel occlusion among patients aged 18 to 55 years. Methods: Between 2007 and 2014, we recruited patients who experienced small-vessel occlusion (according to Trial of Org 10,172 in Acute Stroke Treatment [TOAST] classification) aged 18 to 55 years and conducted a hospital-based follow-up study. The assessed outcomes were mortality, recurrence, and dependency within 3 years after the initial stroke. The outcome determinants were assessed using a multivariate logistic regression analysis. Results: A total of 276 patients (men, 76.09%) with small-vessel occlusions were enrolled in this study. In addition, 85.1% of the patients had strokes between the ages of 45 and 55 years. The risk of recurrence within 3 years was higher for patients who had moderate strokes than for those who had mild events (relative risk [RR], 3.09; 95% confidence interval [CI], 1.14–8.34; P < 0.05). Further, the risk of dependency within 3 years was 2.61 times higher in obese patients than in non-obese patients (RR, 2.61; 95% CI, 1.00–6.79; P < 0.05). The risks of recurrence and dependency within 3 years increased by 17% and 18%, respectively, for each 1-unit increase in fasting plasma glucose levels (RR, 1.17; 95% CI, 1.05–1.30 and RR, 1.18; 95% CI, 1.06–1.32, respectively; both P < 0.05). Conclusion: Our findings suggest that small-vessel occlusions cause the heaviest disease burden in patients aged 45 to 55 years. To reduce stroke recurrence, young and middle-aged patients with small-vessel occlusions should control their fasting plasma glucose levels and manage their weight.

11 May 2023 in Tropical Journal of Pharmaceutical Research
Verified
Journal Article
Open access
PDF file
XWXinping Wang
Xinping Wang
MYMing Yue
Ming Yue
QLQiang Li
Qiang Li
GLGuiling Li
Guiling Li
CXChunmiao Xu
Chunmiao Xu
MTMeiling Tang
Meiling Tang
Purpose: To investigate the effect of saikosaponin A (SSa) on liver fibrosis, and the underlying mechanism of action. Methods: Sprague-Dawley (SD) rats were treated with carbon tetrachloride (CCl4) in an in vivo model of liver fibrosis. The effect of SSa on liver fibrosis was determined by spectrophotometry, Sirius staining, and western blotting. The mechanism of SSa in autophagy and NOD-like receptors containing pyrin domain 3 (NLRP3) inflammasome were examined by western blotting. Results: Saikosaponin A treatment reduced CCl4-induced serum aminotransferase (ALT) and aspartate aminotransferase (AST) levels, hydroxyproline (HYP) content, relative protein expression of alpha-smooth muscle actin (α-SMA), as well as Collagen 1 and deposition of collagenous fiber in liver tissues (p < 0.05). Saikosaponin A administration also downregulated the CCl4-induced protein levels of Hedgehog signaling pathway-related proteins that mediate autophagy and the NLRP3 inflammasome in hepatic tissues (p < 0.05). Conclusion: Saikosaponin A mitigates liver fibrosis by suppressing Hedgehog signaling pathway-mediated autophagy and NLRP3 inflammasome in CCl4-induced rats. Thus, SSa is a potential drug for the management of liver fibrosis.